Hims & Hers Health Acquires Eucalyptus for $1.15B
Analysis based on 10 articles · First reported Feb 19, 2026 · Last updated Feb 19, 2026
The acquisition of Eucalyptus by Hims & Hers Health is expected to positively impact the telehealth and digital health markets by fostering consolidation and global expansion. It positions Hims & Hers Health as a stronger international player, potentially increasing competition and innovation in new markets like Australia and Japan.
Hims & Hers Health Health, Inc. announced its agreement to acquire Australian digital health company Eucalyptus for up to $1.15 billion. This strategic acquisition aims to significantly expand Hims & Hers Health' international presence, particularly in Australia, Japan, the United Kingdom, Germany, and Canada. The deal, expected to close in mid-2026, involves an initial cash payment of approximately $240 million, with the remainder contingent on future performance. Eucalyptus, known for brands like Juniper and Pilot, has served over 775,000 customers and has an annual revenue run-rate of over $450 million. This move comes as Hims & Hers Health navigates a lawsuit from Novo Nordisk and regulatory challenges from the United States===Food and Drug Administration regarding its compounded weight-loss drug. Eucalyptus CEO Tim Doyle will lead Hims & Hers Health' international operations post-acquisition. The acquisition is seen as a strategic pivot for Hims & Hers Health towards international growth and diversification, leveraging Eucalyptus's existing infrastructure and brand recognition in key markets.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard